eMagin Corporation (EMAN)
AMEX: EMAN
· Real-Time Price · USD
2.07
0.06 (2.99%)
At close: Oct 17, 2023, 10:00 PM
eMagin Revenue Breakdown
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|
| Contract Revenue | 1.69M | 1.87M | 4.38M | 2.14M | 2.91M |
| Contract Revenue Growth | -9.79% | -57.33% | +105.05% | -26.64% | n/a |
| Product Revenue | 28.84M | 24.18M | 25.04M | 24.59M | 23.32M |
| Product Revenue Growth | +19.31% | -3.46% | +1.84% | +5.43% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas Revenue | 19.07M | 16.15M | 16.43M | 14.57M | 13.97M | 11.83M | 12.66M | 16.18M | 2.91M | 2.68M | 2.6M |
| Americas Revenue Growth | +18.11% | -1.74% | +12.82% | +4.27% | +18.04% | -6.55% | -21.74% | +456.27% | +8.38% | +3.39% | n/a |
| Asia Pacific Revenue | 1.45M | 1.72M | 3.16M | 1.05M | 3.11M | 2.9M | 1.44M | 2.01M | n/a | n/a | n/a |
| Asia Pacific Revenue Growth | -15.54% | -45.56% | +201.15% | -66.29% | +7.28% | +101.25% | -28.36% | n/a | n/a | n/a | n/a |
| E M E A Revenue | 10.01M | 8.18M | 9.83M | 11.11M | 9.16M | 7.3M | 7.29M | 6.95M | n/a | n/a | n/a |
| E M E A Revenue Growth | +22.35% | -16.82% | -11.50% | +21.35% | +25.46% | +0.08% | +4.94% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 9.02M | 2.81M | 2.08M | 1.73M | 1.9M | 2.17M | 1.86M | 2.2M | 1.69M | 1.82M | 2.23M | 1.82M | 1.71M | 1.8M | 1.7M | 1.84M | 1.78M | 1.94M | 1.99M | 2.04M | 2.03M | 2.91M | 1.98M | 1.97M | 2.15M | 2.46M | 2.37M | 2.04M | 1.99M | 2.01M | 1.91M | 2.18M | 1.74M | 1.13M |
| Selling, General, and Administrative Revenue Growth | +221.60% | +34.79% | +20.43% | -9.24% | -12.26% | +16.54% | -15.48% | +30.36% | -7.35% | -18.32% | +22.42% | +6.54% | -4.78% | +6.01% | -7.78% | +3.49% | -8.35% | -2.32% | -2.65% | +0.39% | -30.25% | +47.37% | +0.30% | -8.50% | -12.59% | +4.06% | +15.97% | +2.41% | -0.85% | +5.07% | -12.37% | +25.53% | +54.17% | n/a |
| Research and Development Revenue | 1.64M | 1.2M | 1.2M | 1.24M | 1.46M | 1.48M | 1.68M | 1.67M | 1.79M | 1.84M | 1.4M | 1.73M | 1.6M | 980K | 1.1M | 1.05M | 1.3M | 1.6M | 1.75M | 1.59M | 1.72M | 1.63M | 1.39M | 1.27M | 1.18M | 1.33M | 1.89M | 1.67M | 1.5M | 1.3M | 1.09M | 1.15M | 929K | 903K |
| Research and Development Revenue Growth | +36.16% | +0.33% | -2.99% | -15.17% | -1.82% | -11.51% | +0.48% | -6.66% | -2.93% | +31.38% | -19.15% | +8.44% | +63.16% | -11.31% | +5.64% | -19.54% | -18.60% | -8.90% | +10.25% | -7.56% | +5.46% | +17.09% | +9.60% | +7.99% | -11.77% | -29.57% | +13.69% | +11.14% | +15.04% | +19.10% | -4.95% | +23.90% | +2.88% | n/a |